As previously noted, pUL36 can inhibit both caspase-8–dependent apoptosis [58] and MLKL-mediated necroptosis, making it a dual-function inhibitor of programmed cell death and a potentially valuable therapeutic target in HCMV infection. This evidence concerns the gene MLKL and cytomegalovirus infection.